Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Marco, Foppoli"'
Autor:
Giulia Marchionni, Sonia Levi, Andrea Pontara, Paolo Santambrogio, Valentina Da Prat, Annalisa Bucchi, Andrés José Maria Ferreri, Milva Zambetti, Marco Foppoli, Luca Gianni, Fabio Ciceri, Alberto Margonato, Gabriele Fragasso
Publikováno v:
European Heart Journal Supplements. 24
Background Anthracyclines effectiveness is burdened by numerous side effects, among which cardiotoxicity (CTX) is the one carrying the highest impact on survival. Prevention of CTX is known to be far more effective than its treatment. Nonetheless, pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b908e0ba6db547dcc36a2ce8fa3a6f7
https://doi.org/10.1093/eurheartjsupp/suac121.124
https://doi.org/10.1093/eurheartjsupp/suac121.124
Autor:
Ilaria Francaviglia, Paolo Lopedote, Filippo Gagliardi, Fabio Ciceri, Sara Steffanoni, Rita Daverio, Teresa Calimeri, Elena Anghileri, Maria Rosa Terreni, Marianna Sassone, Roberto Furlan, Piera Angelillo, Vittoria Tarantino, Maurilio Ponzoni, Chiara Iacona, Claudio Tripodo, Cristina Belloni, Alessandro Gulino, Daniela De Lorenzo, Massimo Filippi, Marica Eoli, Elena Guggiari, Maria Giulia Cangi, Vittorio Martinelli, Massimo Locatelli, Annamaria Finardi, Andrés J.M. Ferreri, Andrea Falini, Nicoletta Anzalone, Marco Foppoli, Alessandro Nonis, Pietro Mortini, Claudio Doglioni, Angelo Diffidenti
Publikováno v:
British Journal of Haematology. 193:497-505
Reliable biomarkers are needed to avoid diagnostic delay and its devastating effects in patients with primary central nervous system (CNS) lymphoma (PCNSL). We analysed the discriminating sensitivity and specificity of myeloid differentiation primary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a40710b52a135ce01768870f9fa808d
https://doi.org/10.1111/bjh.17357
https://doi.org/10.1111/bjh.17357
Autor:
Andrés J. M. Ferreri, Piera Angelillo, Federico Erbella, Chiara Cattaneo, Luisa Verga, Arben Lleshi, Bernardino Allione, Maurilio Ponzoni, Fabio Facchetti, Chiara Pagani, Marco Foppoli, Lorenza Pecciarini, Marianna Sassone, Sara Steffanoni, Elena Flospergher, Giuseppe Rossi, Michele Spina, Alessandro Re
Publikováno v:
Blood advances. 6(22)
Patients with aggressive B-cell lymphoma and MYC rearrangement at fluorescence in situ hybridization exhibit poor outcome after R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone). In the last decade, 68 patients with Burkitt l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3914e86a93e6f7e71ffd358b7b322af2
https://pubmed.ncbi.nlm.nih.gov/35580327
https://pubmed.ncbi.nlm.nih.gov/35580327
Publikováno v:
Computer Aided Chemical Engineering ISBN: 9780323958790
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3219d6524a76d0fd582ab8cc4c2cb019
https://doi.org/10.1016/b978-0-323-95879-0.50076-x
https://doi.org/10.1016/b978-0-323-95879-0.50076-x
Autor:
Sara Steffanoni, Teresa Calimeri, Sarah Marktel, Rosamaria Nitti, Marco Foppoli, Andrés J. M. Ferreri
Publikováno v:
Cancers. 15:526
Background: Consolidation therapy has improved the outcome of newly diagnosed PCNSL patients. Whole-brain radiotherapy (WBRT) was the first consolidation strategy used and represented the gold standard for many years, but at the expense of a high ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b093a9d6189d09d81d9921d10bdff82
https://doi.org/10.3390/cancers15020526
https://doi.org/10.3390/cancers15020526
Publikováno v:
Expert opinion on therapeutic targets. 25(9)
Introduction Primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system (PCNSL) represents a relevant challenge in onco-hematology. Indeed, PCNSL has a specific molecular profile and peculiar biological characteristics that distingui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ce9fc85e25125f05ee780c9dd28429b
https://pubmed.ncbi.nlm.nih.gov/34606736
https://pubmed.ncbi.nlm.nih.gov/34606736
Autor:
C. Cecchetti, Salvatore Perrone, Angelo Corti, Claudio Bordignon, Flavio Curnis, Marianna Sassone, Giovanni Citterio, Maurilio Ponzoni, Andrés J.M. Ferreri, Teresa Calimeri, Letterio S. Politi, Gian Marco Conte, Dario Cattaneo, Marco Foppoli, Eloise Scarano, Fabio Ciceri, Federico Fallanca, Alessandro Nonis, Stefania Girlanda, Nicoletta Anzalone, Paolo Lopedote
Publikováno v:
Blood. 134:252-262
Patients with primary central nervous system lymphoma (PCNSL) are treated with high-dose methotrexate-based chemotherapy, which requires hospitalization and extensive expertise to manage related toxicity. The use of R-CHOP (rituximab, cyclophosphamid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e53d5afc407799da9616493f3f4692df
https://doi.org/10.1182/blood.2019000633
https://doi.org/10.1182/blood.2019000633
Autor:
Alessandro Re, Giulio Rossi, Anna Ferreri, Luisa Verga, M. Ponzoni, Fabio Facchetti, Marco Foppoli, Bernardino Allione, Marianna Sassone, Chiara Cattaneo, Michele Spina, Piera Angelillo, A. Lleshi, Chiara Pagani, F Erbella, C Liberatore, L Pecciarini, E Flospergher
Publikováno v:
Hematological Oncology. 39
Introduction: Patients (pts) with aggressive B-cell lymphoma and MYC rearrangement exhibits poor outcome after R-CHOP treatment. In the last decade, these pts were treated with a new dose-dense, short-term therapy termed “CARMEN”, at several Ital
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::805f160983bbee1b52f538417f2a7480
https://doi.org/10.1002/hon.93_2880
https://doi.org/10.1002/hon.93_2880
Autor:
M. Ponzoni, Piera Angelillo, M. M.B Salvador Chalup, C. Muzi, Maria Dimou, Potito Rosario Scalzulli, F. L. Nogueira, Emilio Iannitto, D. Onofrillo, Anna Ferreri, Marco Foppoli, Monica Tani, F. Cocito, P. Ramakrishnan, Alessia Castellino, T. Calimeri, Vittoria Tarantino, P. L. Zinzani, Kate Cwynarski, Alessandra Tucci, Felicetto Ferrara, T.P. Vassilakopoulos, G. Cabras, Andrew Davies, Luigi Petrucci, Andrea Ferrario, Sotirios G. Papageorgiou, Maria Chiara Tisi, Luca Arcaini
Publikováno v:
Hematological Oncology. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::693874298f208cc255bdc367ba786593
https://doi.org/10.1002/hon.66_2880
https://doi.org/10.1002/hon.66_2880
Autor:
Letterio S. Politi, Daniela De Lorenzo, Andrés J.M. Ferreri, Eltjona Rrapaj, Claudio Bordignon, Vittoria Tarantino, Fabio Ciceri, Angelo Corti, Eloise Scarano, Nicoletta Anzalone, Paolo Lopedote, Gian Marco Conte, Piera Angelillo, Maurilio Ponzoni, Marianna Sassone, Teresa Calimeri, Flavio Curnis, Federico Fallanca, Marco Foppoli, Alessandro Nonis, Giovanni Citterio, Dario Cattaneo, Elena Guggiari, Sara Steffanoni
Publikováno v:
Blood Adv
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is the standard treatment of diffuse large B-cell lymphoma (DLBCL). Primary DLBCL of the central nervous system (CNS) (primary central nervous system lymphoma [PCNSL]) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1f907bf54a5b3914ea150f29affd1b9
https://europepmc.org/articles/PMC7422104/
https://europepmc.org/articles/PMC7422104/